An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021088
Company: ORTHO MCNEIL JANSSEN

Other Important Information from FDA

Products on NDA 021088

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
VIADUR	LEUPROLIDE ACETATE	EQ 65MG BASE	IMPLANT;IMPLANTATION	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021088

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/03/2000	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21088lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21088ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/02-1088_Vidaur.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/14/2011	SUPPL-25	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021088s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021088s025ltr.pdf
09/15/2005	SUPPL-22	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021088s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021088s022ltr.pdf
10/21/2002	SUPPL-16	Manufacturing (CMC)-Control		Label is not available on this site.
08/01/2003	SUPPL-15	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21088slr015ltr.pdf
05/23/2002	SUPPL-14	Manufacturing (CMC)-Control		Label is not available on this site.
08/23/2002	SUPPL-13	Manufacturing (CMC)-Control		Label is not available on this site.
05/23/2002	SUPPL-12	Manufacturing (CMC)		Label is not available on this site.
05/17/2002	SUPPL-11	Manufacturing (CMC)-Control		Label is not available on this site.
08/08/2001	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
08/13/2001	SUPPL-8	Manufacturing (CMC)-Control		Label is not available on this site.
09/08/2005	SUPPL-7	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021088s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021088s007ltr.pdf
07/05/2001	SUPPL-6	Manufacturing (CMC)-Control		Label is not available on this site.
06/08/2001	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
01/24/2001	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
10/16/2000	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
09/28/2000	SUPPL-2	Manufacturing (CMC)-Control		Label is not available on this site.
09/18/2000	SUPPL-1	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 021088

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/14/2011	SUPPL-25	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021088s025lbl.pdf
09/15/2005	SUPPL-22	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021088s022lbl.pdf
09/08/2005	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021088s007lbl.pdf
03/03/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21088lbl.pdf

Top